Celexa /00582602/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 47.8%
Depression 17.4%
Pain 8.7%
Attention Deficit/hyperactivity Disorder 4.3%
Blood Pressure 4.3%
Hypertonic Bladder 4.3%
Liver Transplant 4.3%
Neuropathy Peripheral 4.3%
Scan Myocardial Perfusion 4.3%
Accidental Overdose 20.0%
Renal Failure 20.0%
Skin Warm 20.0%
Speech Disorder 20.0%
Urinary Retention 20.0%
Concomitant
Product Used For Unknown Indication 64.0%
Hepatitis C 9.1%
Pain 4.7%
Depression 4.2%
Rheumatoid Arthritis 3.0%
Anxiety 1.9%
Multiple Sclerosis 1.8%
Back Pain 1.4%
Psoriatic Arthropathy 1.3%
Psoriasis 1.2%
Attention Deficit/hyperactivity Disorder 0.9%
Constipation 0.9%
Nausea 0.9%
Prostate Cancer 0.9%
Hypertension 0.8%
Breast Cancer 0.7%
Muscle Spasms 0.7%
Osteoporosis Postmenopausal 0.7%
Gastrooesophageal Reflux Disease 0.6%
Premedication 0.6%
Vomiting 9.4%
Injection Site Swelling 8.5%
Nausea 7.5%
Drug Ineffective 6.6%
Injection Site Pain 6.6%
Pyrexia 6.6%
Upper Respiratory Tract Infection 6.6%
Sinusitis 5.7%
Weight Decreased 5.7%
Death 4.7%
Medication Error 3.8%
Pain 3.8%
Therapeutic Response Decreased 3.8%
Tremor 3.8%
Hyperhidrosis 2.8%
Injection Site Warmth 2.8%
Product Quality Issue 2.8%
Rheumatoid Arthritis 2.8%
Sleep Disorder 2.8%
Suicidal Ideation 2.8%

Drug Data